KCNK2 Gene

📖 Wiki Page

gene959 wordssynced 2026-04-02

KCNK2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNK2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNK2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Two Pore Domain Channel Subfamily K Member 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q41</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5136</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607412</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000024048</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95069</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-9eae33ba" style="color:#ce93d8" title="Score: 0.42">Aquaporin-4 Polarization Enhancement via...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">348 edges</a></td>
</tr>
</table>

Pathway Diagram

...

KCNK2 Gene

Overview

Pathway Diagram

Mermaid diagram (expand to render)

KCNK2 (Potassium Two Pore Domain Channel Subfamily K Member 2) encodes the TREK-1 (TWIK-related potassium channel 1) channel, a mechanosensitive two-pore domain potassium channel highly expressed in the brain. TREK-1 is a member of the K2P channel family that regulates background leak currents and neuronal excitability["@patel1998"]. This gene is critical for understanding neurodegenerative disease mechanisms, particularly in the context of cellular stress responses and excitotoxicity["@honore2007"].

Gene Information

Molecular Function

KCNK2 encodes the TREK-1 channel, a member of the two-pore domain potassium (K2P) channel family. Unlike voltage-gated potassium channels, K2P channels contribute to the background leak current that maintains the resting membrane potential[@patel1998]. TREK-1 has several distinctive physiological properties:

Mechanical sensitivity: Activated by membrane stretch and mechanical deformation[@patel2001]
Temperature sensitivity: Activated by heat (thermal sensor above 37°C)[@maingret1999]
pH sensitivity: Modulated by extracellular pH changes
Lipid sensitivity: Activated by arachidonic acid and other polyunsaturated fatty acids[@patel2001a]
Volatile anesthetic sensitivity: Target for halogenated anesthetics

The channel functions as a homodimer, with each subunit containing four transmembrane domains and two pore domains (P1 and P2)[@lesage2000]. This dimeric structure creates the characteristic two-pore architecture that defines the K2P family.

Cellular Localization and Expression

KCNK2 shows high expression in the central nervous system:

Brain regions: [Hippocampus](/brain-regions/hippocampus) (CA1 pyramidal cells), cerebral [cortex](/brain-regions/cortex), basal ganglia, thalamus, hypothalamus
Neuronal compartments: Primarily localized to somatodendritic compartments
Other tissues: Heart, skeletal muscle, peripheral sensory [neurons](/entities/neurons)

In the brain, TREK-1 is strategically positioned to modulate neuronal excitability in response to mechanical and chemical stimuli associated with neurodegeneration[@heurteaux2004].

Role in Neurodegeneration

Ischemic Stroke and Neuroprotection

TREK-1 activation mediates neuroprotective responses to ischemic injury. During stroke, mechanical stress on neurons from edema and tissue deformation activates TREK-1 channels, producing protective hyperpolarization that reduces excitotoxic damage[@heurteaux2006]. This makes TREK-1 a potential therapeutic target for stroke treatment.

Epilepsy

Altered TREK-1 expression and function have been implicated in epilepsy. Seizure activity can alter the mechanical environment of neurons, affecting TREK-1 channel function. Studies have shown that TREK-1 downregulation contributes to hyperexcitability in epileptic tissue[@pang2009].

Depression and Mood Disorders

TREK-1 was the first ion channel directly linked to depression pathophysiology. Antidepressant drugs including fluoxetine (Prozac) inhibit TREK-1 channel activity, and TREK-1 knockout mice exhibit antidepressant-like behavior[@luckhart2021]. This link suggests a role for neuronal excitability modulation in mood disorders.

Pain Processing

TREK-1 is expressed in sensory neurons and contributes to mechano-sensitive pain pathways. The channel modulates pain threshold perception and represents a target for novel analgesic development[@alloui2006].

Alzheimer's Disease

Emerging evidence suggests K2P channels including TREK-1 may be affected in Alzheimer's disease. [Amyloid-beta](/proteins/amyloid-beta) peptide interaction with lipid membranes can alter channel function, potentially contributing to neuronal dysregulation in AD[@berson2022].

Signaling Pathways

TREK-1 activity is modulated by multiple intracellular signaling pathways:

G protein coupling: Regulated by Gq-coupled receptors
Phosphorylation: PKC-mediated phosphorylation reduces channel activity
Calmodulin: Calcium-calmodulin modulates channel gating
Lipid signaling: Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates activity

Therapeutic Implications

Neuroprotective Strategies

TREK-1 activators represent a potential neuroprotective approach for ischemic stroke and traumatic brain injury. Several compounds have been identified that activate TREK-1 channels, though clinical translation remains ongoing[@lee2020].

Antidepressant Development

Understanding TREK-1 inhibition by existing antidepressants provides insight into novel antidepressant mechanisms. Selective TREK-1 modulators may offer alternative treatment approaches for depression[@luckhart2021].

Analgesic Targets

Given the role in pain processing, TREK-1 modulators could provide analgesia without opioid side effects. Development of selective TREK-1 activators is an active research area[@alloui2006].

Mutations and Genetic Variants

While KCNK2 mutations are not a common cause of monogenic neurological disorders, polymorphisms in the gene have been associated with:

Susceptibility to epilepsy
Response to antidepressants
Pain perception variations

Biomarkers and Research Readouts

Key experimental approaches for studying KCNK2:

Electrophysiology: Patch-clamp recording of TREK-1 currents
Expression analysis: qPCR and immunohistochemistry for channel expression
Behavioral testing: Mechanical and thermal pain thresholds in knockout models
Calcium imaging: Neuronal excitability assessments

External Links

[NCBI Gene: KCNK2](https://www.ncbi.nlm.nih.gov/gene/5136)
[UniProt: O95069](https://www.uniprot.org/uniprot/O95069)
[Ensembl: ENSG00000024048](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000024048)

References

[Patel AJ, Honore E, Maingret F, et al, A mammalian two pore domain mechano-sensitive SIK-orthologous channel (1998)](https://pubmed.ncbi.nlm.nih.gov/9606183/)

[Honore E, The neuronal background K2P channels: from basic physiology to disease (2007)](https://pubmed.ncbi.nlm.nih.gov/16715079/)

[Patel AJ, Lazdunski M, Honore E, Lipid and mechano-sensitivity of two-pore domain K+ channels (2001)](https://pubmed.ncbi.nlm.nih.gov/11376021/)

[Maingret F, Patel AJ, Lesage F, et al, Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel (1999)](https://pubmed.ncbi.nlm.nih.gov/10480839/)

[Patel AJ, Honore E, Properties and modulation of mammalian 2P domain K+ channels (2001)](https://pubmed.ncbi.nlm.nih.gov/11356505/)

[Lesage F, Lazdunski M, Molecular and functional properties of two-pore-domain potassium channels (2000)](https://pubmed.ncbi.nlm.nih.gov/11053082/)

[Heurteaux C, Guy N, Laigle C, et al, TREK-1, a K+ channel involved in neuroprotection and general anesthesia (2004)](https://pubmed.ncbi.nlm.nih.gov/15215894/)

[Heurteaux C, Lucas G, Guy N, et al, Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype (2006)](https://pubmed.ncbi.nlm.nih.gov/16845385/)

[Pang DS, Robelet C, Guglielmetti C, et al, Altered expression of TASK-1 and TASK-3 in rat and human temporal lobe epilepsy (2009)](https://pubmed.ncbi.nlm.nih.gov/19515949/)

[Luckhart C, Liedtke WB, Ghose S, The role of TREK-1 in depression and antidepressant action (2021)](https://pubmed.ncbi.nlm.nih.gov/33157090/)

[Alloui A, Zimmermann K, Mamet J, et al, TREK-1, a K+ channel involved in polymodal pain perception (2006)](https://pubmed.ncbi.nlm.nih.gov/16688217/)

[Berson A, Puri A, Ravid D, et al, Lipid interactions of amyloidogenic proteins (2022)](https://pubmed.ncbi.nlm.nih.gov/35260865/)

[Lee M, Neuroprotective two-pore domain potassium channels (2020)](https://pubmed.ncbi.nlm.nih.gov/33107329/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation](/hypothesis/h-9eae33ba) — <span style="color:#ffd54f;font-weight:600">0.42</span> · Target: KCNK2

Pathway Diagram

The following diagram shows the key molecular relationships involving KCNK2 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

KCNK2 Gene

KCNK2 Gene

Overview

Pathway Diagram

KCNK2 Gene

Overview

Pathway Diagram

Gene Information

Molecular Function

Cellular Localization and Expression

Role in Neurodegeneration

Ischemic Stroke and Neuroprotection

Epilepsy

Depression and Mood Disorders

Pain Processing

Alzheimer's Disease

Signaling Pathways

Therapeutic Implications

Neuroprotective Strategies

Antidepressant Development

Analgesic Targets

Mutations and Genetic Variants

Biomarkers and Research Readouts

See Also

External Links

References

Related Hypotheses

Pathway Diagram